TSPAN5, ERICH3 and selective serotonin reuptake inhibitors in major depressive disorder: Pharmacometabolomics-informed pharmacogenomics

M. Gupta, D. Neavin, D. Liu, J. Biernacka, D. Hall-Flavin, W. V. Bobo, M. A. Frye, M. Skime, G. D. Jenkins, A. Batzler, K. Kalari, W. Matson, S. S. Bhasin, H. Zhu, T. Mushiroda, Y. Nakamura, M. Kubo, L. Wang, R. Kaddurah-Daouk, R. M. Weinshilboum

Research output: Contribution to journal › Article › peer-review

56 Scopus citations

Fingerprint

Dive into the research topics of 'TSPAN5, ERICH3 and selective serotonin reuptake inhibitors in major depressive disorder: Pharmacometabolomics-informed pharmacogenomics'. Together they form a unique fingerprint.

Medicine & Life Sciences